Published in Women's Health Weekly, December 25th, 2003
According to recent research from South Korea, "this study determined the distribution of high-risk HPV type infection in cervical cancer using newly developed oligonucleotide chips (HPVDNAChips). The study subjects included 80 cases of cervical neoplasia and 746 controls with a normal Pap smear. For HPV genotyping, the commercially available HPVDNAChips was used."
"The risk of cervical cancer was increased in women with a family history of cervical cancer (adjusted OR = 2.3, 95% CI: 0.92-6.17) and in smokers (adjusted OR = 3.2. 95% CI: 1.45-7.06). There was also a trend of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.